BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update

  February 25, 2026

   · 

  13 min read
• Press Releases

  AbCellera Reports Full Year 2025 Business Results

  February 25, 2026

   · 

  12 min read
• Press Releases

  Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March 2026

  February 25, 2026

   · 

  1 min read
• Press Releases

  Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

  February 25, 2026

   · 

  2 min read
• Press Releases

  Inogen Announces $30 Million Share Repurchase Program

  February 25, 2026

   · 

  3 min read
• Press Releases

  Alkermes to Present at the TD Cowen 46th Annual Health Care Conference

  February 25, 2026

   · 

  1 min read
• Press Releases

  Nektar Therapeutics to Participate in Two Investor Conferences in March 2026

  February 25, 2026

   · 

  2 min read
• Press Releases

  Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

  February 25, 2026

   · 

  8 min read
• Press Releases

  Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

  February 25, 2026

   · 

  8 min read
• Press Releases

  HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT

  February 25, 2026

   · 

  7 min read